Collections: Health Policy and Services Research / Subjects: Drug Packaging - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Subjects Drug Packaging ✖

1. Dangers associated with unlabeled basins, bowls, and cups

Publication:: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
Subject(s):: Drug Labeling
Medical Errors -- prevention & control
Medication Errors -- prevention & control
Operating Rooms -- methods
Product Labeling
Surgical Equipment
Drug Packaging
Patient Safety
Product Packaging
Humans
Pennsylvania
United States

2. Recommended statement for over-the-counter aspirin-containing drug products labeled with cardiovascular related imagery

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
Subject(s):: Aspirin
Drug Labeling
Drug Packaging
Nonprescription Drugs
Cardiovascular System
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

3. Mixing, diluting, or repackaging biological products outside the scope of an approved biologics license application

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, January 2018
Subject(s):: Biological Products
Drug Approval
Drug Packaging
Prescription Drugs
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

4. Hidden sources of latex in healthcare products

Publication:: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2004
Subject(s):: Latex -- adverse effects
Latex -- immunology
Latex Hypersensitivity -- immunology
Latex Hypersensitivity -- prevention & control
Occupational Exposure -- adverse effects
Allergens -- adverse effects
Allergens -- immunology
Drug Packaging
Drug Storage
Health Facilities
Humans
United States

5. Poor labeling of respiratory therapy medications can impact patient safety

Publication:: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, [2005]
Subject(s):: Bronchodilator Agents -- therapeutic use
Drug Labeling
Drug Packaging
Medication Errors -- prevention & control
Respiratory System Agents -- therapeutic use
Patient Safety
Respiratory Therapy
Humans
Pennsylvania
United States

6. COVID-19 container closure system and component changes: glass vials and stoppers

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, March 2021
Subject(s):: Drug Packaging
Glass
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

7. Wholesale distributor verification requirement for saleable returned drug product: compliance policy

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, September 2019
Subject(s):: Commerce -- legislation & jurisprudence
Legislation, Drug
Pharmaceutical Preparations -- standards
Drug Labeling
Drug Packaging
Guideline Adherence
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

8. Definitions of suspect product and illegitimate product for verification obligations under the Drug Supply Chain Security Act: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2023
Subject(s):: Drug Industry
Legislation, Drug
Drug Packaging
Drug and Narcotic Control
Government Regulation
United States

9. Enhanced drug distribution security at the package level under the Drug Supply Chain Security Act: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Drug Industry
Drug and Narcotic Control
Drug Packaging
Government Regulation
Security Measures
United States
United States.
United States.

10. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2023
Subject(s):: Biological Products -- administration & dosage
Drug Dosage Calculations
Drug Industry
Drug Labeling
Drug Packaging
Government Regulation
Injections -- standards
Prescription Drugs -- administration & dosage
Product Labeling
Product Packaging
United States